Prospective Study of TW in the Treatment of LN Type V With Gross Proteinuria
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to analyze the clinical effects and adverse reactions of
tripterygium glycosides (TW) and CTX in LN-V patients with gross proteinuria.